The protective role of sRAGE has been shown in pre-clinical models in which sRAGE administration or blockage of membrane RAGE reduce different detrimental injuries triggered by RAGE stimulation, such as myocardial injury [34], neointimal expansion in arterial restenosis [35], and glomerulosclerosis [36]. The gene discussed is AGER; the disease is glomerulosclerosis.